Skip to main content
. 2014 Jun 25;45(3):1193–1199. doi: 10.3892/ijo.2014.2523

Figure 3.

Figure 3

Treatment of SUM149PT cancer cells and CD44+/CD24−/Low CSCs with chemotherapeutic agents. (A) Immunofluorescence analysis showing activation of apoptosis in SUM149PT cancer cells and CD44+/CD24−/Low CSCs treated with 1 μM methotrexate or 1 μM SU9516. Cleaved PARP indicating activation of apoptosis was labeled in green. (B) Graph showing the percentage of apoptotic SUM149PT cancer cells and CD44+/CD24−/Low CSCs following treatment with 1 μM methotrexate or 1 μM SU9516. Experiments were performed in triplicate.